US Patent Issued to Hangzhou Sciwind Biosciences on May 26 for "Five-membered heteroaromatic imidazole compound and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,474, issued on May 26, was assigned to Hangzhou Sciwind Biosciences Co. Ltd (Zhejiang, China).

"Five-membered heteroaromatic imidazole compound and use thereof" was invented by Tao Yu (Shanghai), Lu Gan (Shanghai), Chengde Wu (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel five-membered heteroaromatic imidazole compound and use thereof is disclosed herein. Specifically, disclosed is a compound as shown in formula (III) or a pharmaceutically acceptable salt thereof. Also disclosed is a method for treating a disease related to GLP-1 receptor such as type II diabetes."

The patent was filed on Oct. 31, 2022, u...